According to AgeX Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 195.481. At the end of 2023 the company had a P/S ratio of 103.
Year | P/S ratio | Change |
---|---|---|
2023 | 103 | -83.3% |
2022 | 616 | 114.49% |
2021 | 287 | 254.92% |
2020 | 80.9 | 104.05% |
2019 | 39.7 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |